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In this issue, Lee et al. (2009) present a crystal structure of the human mitochondrial DNA poly-
merase (POLγ). The structure of this heterotrimeric enzyme lays a foundation for understanding 
how POLγ mutations cause human mitochondrial disease and why some antiviral nucleoside 
analogs cause cellular toxicity.In 1890, the German scientist Altmann 
observed mitochondria in tissue sec-
tions from mouse liver and coined 
the term Elementarorganismen, as he 
thought he had found free-living organ-
isms inside the nucleated cell (Altmann, 
1890). We know today that mitochondria 
are not independent at all, despite hav-
ing their own genome. Instead, they rely 
on a large number of nuclear genes for 
their function (Falkenberg et al., 2007). 
Mammalian mitochondrial DNA (mtDNA) 
is a circular, double-stranded DNA mol-
ecule of ?16 kb that only encodes 13 
proteins, essential subunits of the oxi-
dative phosphorylation system. The 
remaining ?1500 mitochondrial proteins 
are encoded in the nucleus, including 
all proteins needed for replication and 
expression of the small mtDNA genome 
(Falkenberg et al., 2007). In this issue of 
Cell, Lee et al. (2009) present the struc-
ture of the human mitochondrial DNA 
polymerase (POLγ), a nuclear-encoded heterotrimeric enzyme that replicates 
the mtDNA genome. The structure of 
POLγ provides insight into the function of 
a unique spacer domain involved in pro-
cessivity and subunit interaction. Muta-
tions in the POLγA subunit are a frequent 
cause of disease, and the Lee et al. study 
now provides a basis for classifying and 
understanding such mutations. Finally, 
the structure will facilitate the develop-
ment of antiviral nucleoside analogs that 
do not affect mtDNA maintenance.
The structure of human POLγ at 3.2 
Å resolution (Lee et al., 2009) is a valu-
able advance as the molecular machin-
ery required for mtDNA replication is 
not well understood (Figure 1). As the 
authors report, crystallization of POLγ 
was not straightforward and required the 
use of mutant versions of both the cata-
lytic (POLγA) and accessory subunits 
(POLγB). The structure shows that POLγ 
is an asymmetric heterotrimer (AB2), 
where only one of the POLγB subunits Cell 139forms extensive contacts with the POLγA 
monomer. These findings are in good 
agreement with a previously published 
crystal structure of POLγB at 2.2 Å reso-
lution (Carrodeguas et al., 2001) and with 
an electron microscopic surface map of 
the POLγ holoenzyme (Yakubovskaya et 
al., 2007). Although the POLγA subunit 
folds into a “right-hand” conformation, 
typical of other polymerases, it contains 
a unique spacer domain that is absent 
from other DNA POL I family members. 
The X-ray structure reveals that part of 
this spacer region belongs to the thumb 
subdomain of the right hand. The spacer 
folds into two subdomains: a globular 
domain associated with intrinsic proces-
sivity (IP) and an accessory subunit-inter-
acting domain (AID). The IP subdomain 
interacts with the primer-template DNA 
complex and helps to explain why POLγA 
remains relatively processive even in the 
absence of the POLγB subunits. The AID 
contacts one of the two PolγB subunits. , October 16, 2009 ©2009 Elsevier Inc. 231
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Lee et al. provide model-
ing data that argue against 
direct contacts between the 
accessory factor POLγB and 
the primer-template DNA. 
Instead, the POLγB subunits 
increase processivity by 
affecting POLγA conforma-
tion so that it interacts with 
a longer stretch of template 
DNA.
POLγ cannot on its own 
replicate mtDNA, but requires 
a set of additional proteins. In 
vitro biochemistry has allowed 
the reconstitution of a minimal 
replisome that is able to carry 
out leading strand mtDNA 
replication (Falkenberg et al., 
2007). In addition to POLγ, the 
minimal replisome contains 
the hexameric TWINKLE heli-
case, and the mitochondrial 
single-stranded DNA-binding 
protein (mtSSB) (Falkenberg et al., 2007). 
The mitochondrial RNA polymerase 
(POLRMT) provides the primers required 
for initiation of both leading- and lagging-
strand DNA synthesis (Falkenberg et al., 
2007; Wanrooij et al., 2008). The crystal 
structure reported by Lee et al. (2009) 
will facilitate a detailed structure-function 
analysis of the mitochondrial replisome. 
Interestingly, there is a possible TWIN-
KLE-interacting surface in the POLγA 
spacer region and this predicted contact 
site is an obvious candidate for experi-
mental validation by biochemical assays.
Mutations in mtDNA are a com-
mon cause of mitochondrial diseases. 
Affected patients present a variety of 
symptoms, and it is therefore not surpris-
ing that mutations in POLγ, the enzyme 
that copies mtDNA, can also cause dis-
ease phenotypes in humans such as 
cerebral cortical atrophy with liver fail-
ure (Alpers syndrome), necrotic lesions 
in the basal ganglia (Leigh syndrome), 
ataxia, neuropathy, epilepsy, myopathy, 
external ophthalmoplegia, and cognitive 
impairment, among others (Copeland, 
2008). Many disease mutations map to 
the catalytic POLγA subunit, including 
the spacer region, with few mutations 
found in the POLγB accessory subunit 
(Copeland, 2008). The effects of muta-
tions in the catalytic region have been 
readily elucidated on the basis of com-
parisons with other polymerase struc-
tures. However, because the spacer 
region is absent in other DNA poly-
merase I family members, the structural 
effects of mutations in the spacer have 
been difficult to predict. The Lee et al. 
study now allows the classification of 
mutations according to structural fea-
tures and the authors present a first 
attempt along these lines. One example 
is the W748S mutation, which has been 
associated with autosomal-recessive 
ataxia in adults and the Alpers syndrome 
in children. The structure demonstrates 
that W748 is important in maintaining the 
local structure of the IP domain and that 
the residue forms stacking-interactions 
with F750 and H733. Destabilizing this 
stack can undermine the POLγA interac-
tion with template DNA and lead to lower 
polymerase activity.
Many of the proteins involved in replica-
tion and transcription of mtDNA, including 
POLγA, have homologs in bacteriophages 
(Falkenberg et al., 2007). This relationship 
to bacteriophage DNA replication proteins 
may provide an explanation for the mito-
chondrial toxicity caused by some antiviral 
nucleoside analogs, a well-known problem 
in the treatment of HIV infections (Lewis 
and Dalakas, 1995). The POLγ structure 
now opens up new avenues for the molec-
ular design of nucleoside analogs that lack 
this side effect. Lee et al. found several im-
portant structural differences 
between human POLγ and the 
HIV reverse transcriptase, e.g., 
the nucleotide-binding sites 
formed between the palm and 
fingers subdomains are struc-
turally distinct between the 
two polymerases, a feature 
that may be used for intelligent 
drug design.
Somatic mutations in 
mtDNA are implicated in the 
aging process and there is 
biochemical evidence to sug-
gest that endogenous repli-
cation errors by POLγ rather 
than unrepaired damage to 
mtDNA are the most impor-
tant source of mtDNA muta-
tions in human tissues (Zheng 
et al., 2006). Consistent with 
this idea, mtDNA mutator 
mice, which have a homozy-
gous knockin mutation dis-
rupting POLγA proofreading, accumulate 
substantial amounts of mtDNA point 
mutations and develop a premature aging 
syndrome (Falkenberg et al., 2007). Fur-
thermore, maternal transmission of point 
mutations derived from these mtDNA 
mutator mice creates mouse lines with 
mtDNA mutation patterns that resemble 
those observed in natural populations of 
mice and humans (Stewart et al., 2008). 
It is thus possible that POLγ replication 
errors are an important source of mtDNA 
mutations in mammals. The POLγ struc-
ture should facilitate the development of a 
variant enzyme with increased proofread-
ing capacity. Such an antimutator POLγ 
will be an important experimental test of 
the hypothesis that intrinsic replication 
errors rather than unrepaired DNA dam-
age is the main explanation for sequence 
variations of mammalian mtDNA.
In summary, the elucidation of the 
structure of POLγ is an important mile-
stone toward a molecular understanding 
of mtDNA replication, having in addition 
a number of exciting implications for 
human disease.
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figure 1. mitochondrial Replication and Human disease
The mitochondrial DNA polymerase (POLγ) is the only DNA polymerase in 
mammalian mitochondria. The heterotrimeric POLγ together with the mtDNA 
helicase (also denoted TWINKLE) and additional factors form the replisome 
responsible for replicating mtDNA. Mutations in the catalytic subunit of POLγ 
are a surprisingly common cause for human mitochondrial disease. Antiviral 
nucleoside analogs are sometimes recognized by POLγ and can cause drug 
side effects by interfering with mtDNA replication. POLγ replication error may 
be responsible for generating the majority of the mtDNA mutations implicated 
in age-associated disease and aging.
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